Fagron NV (LON:0HNZ)
20.58
+0.02 (0.12%)
At close: Oct 17, 2025
Fagron NV Market Cap
Fagron NV has a market cap or net worth of 1.35 billion as of October 23, 2025. Its market cap has increased by 16.97% in one year.
Market Cap
1.35B
Enterprise Value
1.62B
Revenue
787.55M
Ranking
n/a
PE Ratio
18.33
Stock Price
20.58
Market Cap Chart
Since October 15, 2007, Fagron NV's market cap has increased from 217.33M to 1.35B, an increase of 519.62%. That is a compound annual growth rate of 10.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 1.34B | 32.91% |
| Dec 31, 2024 | 1.01B | -4.00% |
| Dec 29, 2023 | 1.05B | 22.70% |
| Dec 30, 2022 | 857.92M | -5.27% |
| Dec 31, 2021 | 905.64M | -26.49% |
| Dec 31, 2020 | 1.23B | 4.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.46B |
| HSBC Holdings | 170.19B |
| Shell | 159.91B |
| Unilever | 115.84B |
| Rolls-Royce Holdings | 92.79B |
| Rio Tinto Group | 88.76B |
| British American Tobacco p.l.c. | 82.97B |
| GSK plc | 66.45B |